Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group Block Versus Interscalene Brachial Plexus Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries

NCT ID: NCT06765278

Last Updated: 2025-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-13

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare between Anterior glenoid nerve block, pericapsular nerve group (PENG) block and Interscalene brachial plexus (ISB) block for post-operative pain management in shoulder arthroscopic surgeries

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Major surgeries of the shoulder constitute some of the most commonly performed orthopedic procedures. They often result in moderate to severe postoperative pain thereby requiring a multimodal analgesic approach centered around peripheral nerve blocks.

Postoperative pain management is the part of shoulder surgery to improve patient satisfaction, start rehabilitation process rapidly and decrease for hospital stay.

Interscalene blocks (ISB) are well-studied and established means of providing analgesia following shoulder surgery and are considered the gold standard mode of regional anesthesia and post-operative pain management in shoulder surgeries.

A novel technique: pericapsular nerve group (PENG) block can be effectively and safely applied under ultrasound guidance in shoulder surgery cases for postoperative analgesia. In addition, PENG block targets articular branches with less motor effect compared with interscalene brachial plexus block providing anesthetic and analgesic effect with less complication and better and sooner ambulation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anterior Glenoid Nerve Block Pericapsular Nerve Group Block Interscalene Brachial Plexus Block Postoperative Pain Shoulder Arthroscopic Surgeries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interscalene brachial plexus block group

Patients will receive an Interscalene brachial plexus block.

Group Type ACTIVE_COMPARATOR

Interscalene brachial plexus block

Intervention Type OTHER

Patients will receive an Interscalene brachial plexus block.

Anterior glenoid nerve block group

Patients will receive an anterior glenoid nerve block.

Group Type EXPERIMENTAL

Anterior glenoid nerve block

Intervention Type OTHER

Patients will receive an anterior glenoid nerve block.

Pericapsular nerve group (PENG) block group

Patients will receive a pericapsular nerve group (PENG) block.

Group Type EXPERIMENTAL

Pericapsular nerve group block

Intervention Type OTHER

Patients will receive a pericapsular nerve group (PENG) block.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interscalene brachial plexus block

Patients will receive an Interscalene brachial plexus block.

Intervention Type OTHER

Anterior glenoid nerve block

Patients will receive an anterior glenoid nerve block.

Intervention Type OTHER

Pericapsular nerve group block

Patients will receive a pericapsular nerve group (PENG) block.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age from 18 to 70 years.
* No sex predilection.
* American Society of Anesthesiology (ASA) physical status I-II.
* Undergoing shoulder arthroscopic surgeries.

Exclusion Criteria

* Patient's refusal.
* Patients with a history of drug allergies to study drugs.
* Evidence of local infection at the site of injection.
* Inability to cooperate
* Neuromuscular pathology (example: - Multiple Sclerosis)
* Previous trauma or surgery to the shoulder
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Serry

Assistant Lecturer of Anaesthesia, Intensive Care and Pain Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams University

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohamed Serry, Master

Role: CONTACT

00201002609476

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohamed Serry, Master

Role: primary

00201002609476

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMASU MD195/2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.